In this note, the authors describe the implementation of the “hypothetical monopolist SSNIP test” for market definition in the context of merger cases where firms produce multiple differentiated products.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...


